We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
Oculis Holding AG ("Oculis") a global biopharmaceutical company purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”).
The German life science and medtech investor SHS Gesellschaft für Beteiligungsmanagement mbH has made a EUR 10 million investment in Simulands AG, a Zurich-based manufacturer of simulation devices for medical training of cardiovascular interventions.
E3 Holding AG, Germany, has acquired the clean-tek group from Felix Ritter.
Clean-tek is one of the pioneers in cleanroom technology - technology for sensitive areas such as pharmaceutical production, medical technology,...
Invision has launched and successfully closed Invision Logistics LP, a CHF 145m continuation fund for the further development of Schneider Group.
AFINUM has sold its stake in Cotta Collection AG Upholstered Furniture-Group to L-GAM and to Gschwend AG.
Cotta is a manufacturer of upholstered furniture in the low to medium price segment with two plants in Poland and one plant in Romania.
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative.
Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies.
EBL has been active in the telecom business since 2000 and owns telecom networks in around 200 communities in Switzerland. At the same time, EBL has been successfully pursuing a strong expansion of its business with renewable...
QoQa Brew SA, a subsidiary of QoQa Services SA, financed its craft brewery through a security token offering.
Mosanna Therapeutics AG, a Basel-based biotechnology company developing the advanced small molecule MOS118 (formerly know as AVE0118) for the treatment of metabolic obstructive sleep apnea, closes a Seed Financing Round led by Forty51 Ventures.
Displaying results 31 to 40 out of 166